Latest Breaking News On - Cardiovascular risk reduction - Page 2 : comparemela.com

New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups

Findings Presented on VASCEPA/VAZKEPA Utility in REDUCE-IT Patient Subgroups by Baseline High/Low Lp, LDL-C Levels Lp Results Published Simultaneously in the Journal of the American.

Nova scotiaUnited arab emiratesNew jerseyUnited statesUnited kingdomGreat britainColl cardiolClin cardiolMark marmurNabil abadirAmerican heart associationGlobenewswire incDrug administrationAmerican college of cardiologyHead of global medical affairsJournal of the american college cardiology

New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups

New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

New jerseyUnited statesUnited kingdomUnited arab emiratesGreat britainColl cardiolClin cardiolNabil abadirMark marmurDrug administrationJournal of the american college cardiologyAmerican heart associationExchange commissionEuropean unionA report from the american heart associationHead of global medical affairs

New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups

New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

New jerseyUnited statesUnited arab emiratesUnited kingdomGreat britainColl cardiolClin cardiolMark marmurNabil abadirJournal of the american college cardiologyExchange commissionA report from the american heart associationAmarin corporationEuropean unionDrug administrationAmerican heart association

International Study ID s 13-Biomarker Panel for Predicting Cardiovascular Disease in Type 2 Diabetes

A systematic review of over 400 studies in type 2 diabetes reveals 13 biomarkers, including NT-proBNP and troponin-t, with potential to significantly enhance cardiovascular disease risk prediction.

United statesUnited kingdomRonald maMariaf gomezAmerican diabetes associationEuropean association for the study of diabetesChinese university of hong kongPrecision medicine in diabetes initiativeChinese university of hong kong ronald maKinneym international consortiumLund university diabetes centreLund universityChinese universityHong kongPrecision medicineDiabetes initiative

New REDUCE-IT® Analyses Show VASCEPA® (icosapent ethyl) Associated with 29 Percent Relative Risk Reduction Compared with Placebo in Prespecified Subgroup of Patients with Metabolic Syndrome, but Without Diabetes at Baseline

New REDUCE-IT® Analyses Show VASCEPA® (icosapent ethyl) Associated with 29 Percent Relative Risk Reduction Compared with Placebo in Prespecified Subgroup of Patients with Metabolic Syndrome, but Without Diabetes at Baseline
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United arab emiratesUnited statesUnited kingdomNew jerseyGreat britainClin cardiolColl cardiolMark marmurExchange commissionAmarin corporationDrug administrationEuropean unionA report from the american heart associationAmerican heart associationAnalyses showRelative risk reduction compared